Cargando…
Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
Daptomycin is a lipoglycopeptide antibacterial drug that is rapidly bactericidal for methicillin-resistant Staphylococcus aureus (MRSA) infection and has antibiotic activity against a wide range of Gram-positive organisms. It has been approved by the Ministry of Health, Labor and Welfare in Japan fo...
Autores principales: | Hagihara, Mao, Umemura, Takumi, Mori, Takeshi, Mikamo, Hiroshige |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284219/ https://www.ncbi.nlm.nih.gov/pubmed/22368449 http://dx.doi.org/10.2147/TCRM.S23875 |
Ejemplares similares
-
Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis
por: Parlato, Ciro, et al.
Publicado: (2011) -
In Vitro Efficacy of Antibiotic Combinations with Carbapenems and Other Agents against Anaerobic Bacteria
por: Umemura, Takumi, et al.
Publicado: (2022) -
Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012) -
A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients
por: Kato, Hideo, et al.
Publicado: (2022) -
Elasnin Effectively Eradicates Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Biofilms
por: Sulaiman, Jordy Evan, et al.
Publicado: (2022)